rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

AtriCure, Inc.

ATRC · Nasdaq

Health CareMedical DevicesLeading

ATRC stood above a rising 150-day average in 23 of the last 52 weekly readings, including each of the last 9 weeks. It is 48.9% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
9 in a row
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$8.1M
Officials’ trades on record
13
Institutions holding
237 (+32)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 23 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$2.7M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

13 disclosed lines: House 13, Senate 0, executive 0; 3 people.

WhoDidAmountTraded
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k29 Sep 2026filed 12 Oct 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k20 Aug 2026filed 10 Sep 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k3 Mar 2026filed 7 Apr 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k6 May 2025filed 6 Jun 2025
Josh Gottheimer House: U.S. House ClerkNJ05boughtjoint$1k–$15k19 Jul 2024filed 15 Aug 2024
Josh Gottheimer House: U.S. House ClerkNJ05soldjoint$1k–$15k18 Jun 2024filed 9 Jul 2024
Josh Gottheimer House: U.S. House ClerkNJ05sold$1k–$15k8 Jun 2021filed 15 Jul 2021
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39sold$1k–$15k30 Apr 2020filed 13 May 2020
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39bought$1k–$15k31 Mar 2020filed 16 Apr 2020
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39sold$1k–$15k21 Feb 2020filed 10 Mar 2020
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39bought$1k–$15k7 Nov 2019filed 11 Dec 2019
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39bought$1k–$15k27 Jun 2019filed 12 Jul 2019

Insiders

Buy orders, 12 months0
Sale orders, 12 months17
Buyers · sellers0 · 8
WhoDidSharesTraded
Salvatore PriviteraChief Technical Officersold4,519at $60.0023 Sep 2026filed 24 Sep 2026
Regina E. GrovesDirectorsold5,313at $54.2211 Sep 2026filed 14 Sep 2026
Salvatore PriviteraChief Technical Officersold3,657at $55.008 Sep 2026filed 10 Sep 2026
Salvatore PriviteraChief Technical Officersold7,763at $52.502 Sep 2026filed 4 Sep 2026
Karl S. DahlquistChief Legal Officersold9,370at $48.8924 Aug 2026filed 26 Aug 2026
Karen PrangeDirectorsold3,564at $38.805 Aug 2026filed 7 Aug 2026
Maggie YuenDirectorsold3,500at $38.425 Aug 2026filed 7 Aug 2026
Justin J. NozneskyChief Mktg & Strategy Officersold6,182at $38.8029 Jul 2026filed 30 Jul 2026
Sven WehrweinDirectorsold25,000at $37.8428 Jul 2026filed 30 Jul 2026
Vinayak DoraiswamyChief Scientific Officersold6,000at $38.8828 Jul 2026filed 30 Jul 2026
Karen PrangeDirectorsold3,000at $28.6520 May 2026filed 22 May 2026
Vinayak DoraiswamyChief Scientific Officersold5,000at $28.1315 May 2026filed 18 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders237+32 on the quarter
New · exited54 · 22
Reported value$1.4B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20264,474,548$125.2M+431,867+10.7%
WELLINGTON MANAGEMENT GROUP LLPadded · filed 14 Aug 20263,495,603$97.8M+113,048+3.3%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20263,127,195$87.5M+424,563+15.7%
Hood River Capital Management LLCreduced · filed 14 Aug 20262,905,299$81.3M-212,246−6.8%
ALLIANCEBERNSTEIN L.P.reduced · filed 14 Aug 20262,768,365$79.0M-490,507−15.1%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20262,190,413$61.3M+34,649+1.6%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.reduced · filed 14 Aug 20261,734,279$48.5M-70,648−3.9%
GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 20261,597,988$44.7M-69,178−4.1%
STATE STREET CORPadded · filed 7 Aug 20261,389,989$38.9M+87,827+6.7%
MARSHALL WACE, LLPreduced · filed 13 Aug 20261,333,904$37.3M-133,620−9.1%
31 Mar 2023 – 30 Jun 2026
174205235Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Gilbert Ray Cisneros, Jr. HouseCA31 · last 29 Sep 20267 · 3
Salvatore Privitera Company insiderChief Technical Officer · last 23 Sep 20261 · 14
Regina E. Groves Company insiderDirector · last 11 Sep 20263 · 5
Karl S. Dahlquist Company insiderChief Legal Officer · last 24 Aug 20260 · 8
Karen Prange Company insiderDirector · last 5 Aug 20260 · 4
Maggie Yuen Company insiderDirector · last 5 Aug 20260 · 4
Michael H. Carrel Company insiderPresident, CEO, & Director · last 30 Jul 20260 · 26
Justin J. Noznesky Company insiderChief Mktg & Strategy Officer · last 29 Jul 20260 · 18
Sven Wehrwein Company insiderDirector · last 28 Jul 20260 · 6
Vinayak Doraiswamy Company insiderChief Scientific Officer · last 28 Jul 20260 · 7
Douglas J. Seith Company insiderChief Operating Officer · last 30 Jun 20262 · 15
B. Kristine Johnson Company insiderDirector · last 18 May 20261 · 0

Same industry

RCEL Avita MedicalLeading+100%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202575.0%
Operating profit marginFY 2025 · to 31 Dec 2025-1.8%
Free cash flow marginFY 2025 · to 31 Dec 20259.0%
Return on capital employedFY 2025 · to 31 Dec 2025-1.6%
Debt to equityFY 2025 · to 31 Dec 20250.13×
Research spendFY 2025 · to 31 Dec 202518.6%
Share count trendFY 2025 · to 12 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$167.4M
Free cash flowFY 2025 · to 31 Dec 2025$48.3M

Analyst forecasts

No analyst forecasts yet.